Trial site
Royalderm Agnieszka Nawrocka
- 14running trials
- 14closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)9 trials
- Hidradenitis suppurativa7 trials
- Alopecia areata4 trials
- Chronic spontaneous urticaria3 trials
- Vitiligo2 trials
- Lupus (SLE)1 trial
- Psoriasis1 trial
- Phase
- Phase 320 trials
- Phase 25 trials
- Phase 2/33 trials
- Status
- Completed14 trials
- Active, not recruiting12 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Pfizer4 trials
- Incyte Corporation3 trials
- Novartis Pharmaceuticals3 trials
- Amgen2 trials
- Boehringer Ingelheim2 trials
- and 14 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Completed
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Site data: ClinicalTrials.govUpdated 15 Nov 2026